Preview

Meditsinskiy sovet = Medical Council

Advanced search

Nutrition features of young children with oncological diseases in the process of antitumor treatment

https://doi.org/10.21518/2079-701X-2019-11-200-204

Abstract

Carrying out antitumor treatment of children with oncological diseases is often accompanied by many complications, one of the most significant eating disorders. These disorders can aggravate the existing problems, complicate the patient’s treatment and often dictate the need for special nutritional support. First of all, it is based on the limitations associated with the requirements for low microbial density of food (due to sharply reduced immunity), gastrointestinal disorders of varying severity and prevalence, peculiarities of taste and appetite of the child (which are almost always violated in the process of antitumor therapy), as well as psychological problems. In children of early age, this situation is very significant, since complications (especially gastrointestinal complications) can last for a long time, which may limit the development of the child, even if the basic treatment is successfully completed, or even prevent him or her from developing at all. Therefore, such patients need special nutritional support: enteral and often parenteral nutrition, as well as a special approach to diet, which is often based on industrial baby food products.

About the Authors

A. Yu. Vashura
Federal State Budgetary Institution «National Medical Research Center of Children’s Hematology, Oncology and Immunology named after Dmitry Rogachev» of the Ministry of Health of the Russian Federation
Russian Federation

Vashura Andrey Yurievich – Cand. of Sci. (Med), Nutritionist, Head of the Department of Scientific Basics of Nutrition and Nutritive Metabolic Therapy of the Medical and Rehabilitation Research Center «Russian Field»

142321, Moscow region, Chekhovskiy district, Stremilovskoye, Grishenki village



Ju. A. Alymova
Federal State Budgetary Institution «National Medical Research Center of Children’s Hematology, Oncology and Immunology named after Dmitry Rogachev» of the Ministry of Health of the Russian Federation
Russian Federation

Alymova Julia Aleksandrovna – Pediatrician of the Department of Nutritional Support

117198, Moscow, Samory Mashela St., 1



References

1. Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.

2. Arpaci T., Toruner E.K., Altay N. Assessment of Nutritional Problems in Pediatric Patients with Cancer and the Information Needs of Their Parents: A Parental Perspective. Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):231-236.

3. Barber M.D. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 2002(17):203–9.

4. Withycombe J.S., Smith L.M., Meza J.L., Merkle C., Faulkner M.S., Ritter L., Seibel N.L., Moore K. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62:434–9.

5. Romero-Corral A., Somers V.K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M.D., Parati G., Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010 Mar;31(6):737-46.

6. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297–308.

7. Onesti J.K., Guttridge D.C. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014;2014:168407

8. Livshits Z., Rao R.B., Smith S.W. An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am. 2014 Feb;32(1):167-203. doi: 10.1016/j.emc.2013.09.002.

9. Schcolnik-Cabrera A., Chavez-Blanco A., Dominguez-Gomez G., Duenas-Gonzalez A. Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. Am J Cancer Res. 2017 May 1;7(5):1107-1135.

10. Bing C., Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care. 2008;11:201–207.

11. Esper D.H., Harb W.A. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract. 2005;20:369– 376.

12. Curra M., Soares Junior L.A.V., Martins M.D., Santos P.S.D.S. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo). 2018;16(1):eRW4007.

13. Brinksma A., Huizinga G., Sulkers E., et al. Malnutrition in childhood cancer patients: A review on its prevalence and possible causes. Critical Reviews in Oncology / Hematology. 2012;83:249-275.

14. Wedrychowicz A., Spodaryk M., KrasowskaKwiecień A., Goździk J. Total parenteral nutrition in children and adolescents treated with high-dose chemotherapy followed by autologous haematopoietic transplants. Br J Nutr. 2010 Mar;103(6):899–906.


Review

For citations:


Vashura AY, Alymova JA. Nutrition features of young children with oncological diseases in the process of antitumor treatment. Meditsinskiy sovet = Medical Council. 2019;(11):200-204. (In Russ.) https://doi.org/10.21518/2079-701X-2019-11-200-204

Views: 810


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)